-- Boston Scientific (BSX) has an average rating of Buy and mean price target of $96.45, according to analysts polled by FactSet.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
Price: $64.59, Change: $+5.07, Percent Change: +8.52%
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:FR reported Q1 revenue of $195M (+10.0% Y/Y, $4M above consensus) vs $177M in the prior-year period. Cash same-store NOI increased 8.7% Y/Y to $134M, representing a significant acceleration from 3.7% growth in Q4 2025. The company achieved robust cash rental rate increases of 31.7% in Q1 (51.9% on straight-line basis), while signing 46 leases covering 2.4M sqft during the quarter. Management maintained full-year 2026 guidance for same-store NOI growth of 5%-6%, unchanged from the prior quarter. Leasing activity improved sequentially from 1.8M sqft in Q4 to 2.4M sqft in Q1, demonstrating continued momentum in the leasing environment and strong tenant demand. The notable acceleration in same-store NOI growth appears attributable to weaker Q4 renewal activity that created favorable Y/Y comparisons for Q1. The strong rental rate spreads and increased leasing volume suggest healthy underlying market fundamentals continue.
Crude oil futures advanced in midday trading on Wednesday, buoyed by reports of gunfire attacks on container vessels in the Strait of Hormuz and a sharper-than-expected decline in US fuel inventories.Front-month West Texas Intermediate crude futures jumped by 3.57% to $92.87 per barrel, while Brent futures rose 3.22% to $101.65/bbl.US crude stockpiles rose by 1.9 million barrels to 465.7 mmbbls in the week ended April 17, the Energy Information Administration said in its weekly report on Wednesday. Crude inventories are now about 3% above the five-year average for this time of year, the EIA said.The agency said that US gasoline stocks fell by 4.6 mmbbls to 228.4 million barrels and distillate stockpiles by 3.4 mmbbls to 108.1 mmbbls."Higher oil and fuel prices have already triggered around 5 million b/d of demand destruction," Saxo Bank strategists said, citing Vitol.The analysts said that market stress remains evident in the refined products space, where shortages of diesel, jet fuel, and petrochemical feedstocks continue to underpin prices.The US and Iran remain deadlocked on several key issues, including Tehran's nuclear capabilities and Israel's war with Hezbollah in Lebanon.Soojin Kim, a research analyst at MUFG, said that with key disputes unresolved, including nuclear concerns and regional conflicts, the oil market remains highly sensitive to geopolitical developments and is supported by ongoing supply disruptions.Iran's Revolutionary Guards said its naval forces stopped two ships attempting to cross the Hormuz on Wednesday and directed them to Iranian territorial waters. MarineTraffic said the two vessels are both operated by MSC.The attacks come days after US forces stopped and boarded a sanctioned oil tanker, after seizing a cargo ship over the weekend, and said it has directed 29 vessels to return to port as Washington steps up its campaign to disrupt Iran's shipping network.The UK Maritime Trade Operations said that at least three vessels were targeted by gunfire in the Strait, as the Revolutionary Guards warned that any disruption to order and safety in the strategic waterway would be considered a "red line."Meanwhile, Trump said in a social media post that if the US lifted its blockade to open the Strait, there could never be a deal with Iran.The US President said that a ceasefire would stay in effect until a "seriously fractured" Iranian leadership can come up with a unified proposal for a permanent resolution. However, Iran has accused the US of breaching its commitments under a 10-point framework that it offered at the start of a fragile ceasefire.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:GL posted Q1 2026 operating EPS of $3.43 vs. $3.07 prior year, beating our conservative $3.35 estimate but missing the $3.48 consensus view. Revenue rose 5.4%, in line with our 3% to 8% forecast, driven by 6% premium growth reflecting 3% life and 13% health premium increases. Strong sales momentum included 6% life sales growth and a 58% surge in health sales, with United American Division's health net sales exploding 122% Y/Y to $61.5M. Management raised 2026 operating EPS guidance to $15.40-$15.90 from $14.95-$15.65, suggesting confidence despite investment income pressures. We expect similar premium growth trajectories in 2026, projecting 2% to 6% life premium growth and 5% to 9% health premium increases. Agent count trends present mixed signals, with Liberty National and Family Heritage expanding 9% and 10% respectively, while American Income declined 4%. We are eager to hear management's perspective on middle-market consumer demand trends.